Fecal Calprotectin and Quality of Life Questionnaires Are Responsive to Change in Pouch Disease Activity After Antibiotic Therapy: Results From a Prospective Clinical Trial-Reference-Cited by-同舟云学术

Fecal Calprotectin and Quality of Life Questionnaires Are Responsive to Change in Pouch Disease Activity After Antibiotic Therapy: Results From a Prospective Clinical Trial

Published:2022-09-30 Issue:2 Volume:118 Page:367-370
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Ollech Jacob E.,Yanai Henit,Avni-Biron Irit,Snir Yifat,Banai Hagar,Barkan Revital,Godny Lihi,Wasserberg Nir,White Ian,Dotan Iris

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference10 articles.

1. Pouchitis after ileal pouch-anal anastomosis: A pouchitis disease activity index;Sandborn;Mayo Clin Proc,1994

2. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease;D'Haens;Inflamm Bowel Dis,2012

3. Non-invasive fecal Immunochemical testing and fecal calprotectin predict mucosal healing in inflammatory bowel disease: A prospective cohort study;Ma;Inflamm Bowel Dis,2017

4. Level of fecal calprotectin correlates with endoscopic and histologic inflammation and Identifies patients with mucosal healing in ulcerative colitis;Theede;Clin Gastroenterol Hepatol,2015

5. Consecutive monitoring of fecal calprotectin and lactoferrin for the early diagnosis and prediction of pouchitis after restorative proctocolectomy for ulcerative colitis;Yamamoto;Am J Gastroenterol,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study;Annals of Medicine;2024-05-30

2. Challenges in IBD Research 2024: Pragmatic Clinical Research;Inflammatory Bowel Diseases;2024-05-01

3. Ileoanaler Pouch: Fäkales Calprotectin bildet Entzündungsaktivität ab;Zeitschrift für Gastroenterologie;2023-07